Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Improved mitochondrial efficiency can support more stable energy levels and better recovery from physical or metabolic stress
IC50 values (the concentration required to inhibit 50% of enzyme activity) for 5-Amino-1MQ against NNMT are in the low micromolar range (approximately 25 M in published in vitro assays), while IC50 values for structurally related methyltransferases are orders of magnitude higher, suggesting high specificity
The molecule was developed by the Australian pharmaceutical company Metabolic Pharmaceuticals (in collaboration with Monash University) and advanced through Phase I safety trials and a Phase IIb obesity efficacy trial enrolling approximately 900 participants in total
By stimulating lipolysis (fat breakdown) and inhibiting lipogenesis (fat accumulation), AOD-9604 offers a unique non-stimulant approach to weight management
The compound was first characterized in metabolic research exploring the role of NNMT in adipose tissue biology
Failure to do so will result in return of the anemia and in development of incapacitating and irreversible damage to the nerves of the spinal cord
US$ 28.66
US$ 27.23
US$ 24.73
US$ 21.47
US$ 23.81
US$ 24.02
